Jon Hartas

Evaluation of safety and immunogenicity of a group A streptococcus vaccine candidate (MJ8VAX) in a randomized clinical trial

Silvana Sekuloski, Michael R. Batzloff, Paul Griffin et al. · PLoS ONE · 2018 · 82 citations · Full text

Vir typing: a long-PCR typing method for group A streptococci.

Don L. Gardiner, Jon Hartas, Bart J. Currie et al. · Genome Research · 1995 · 81 citations · Full text

Intranasal Vaccination with a Lipopeptide Containing a Conformationally Constrained Conserved Minimal Peptide, a Universal T Cell Epitope, and a Self‐Adjuvanting Lipid Protects Mice from Group A Streptococcus Challenge and Reduces Throat Colonization

Michael R. Batzloff, Jon Hartas, Weiguang Zeng et al. · The Journal of Infectious Diseases · 2006 · 73 citations · Full text

Microbial Pathogens, Immunology, Immunodominance +24

Conserved anchorless surface proteins as group A streptococcal vaccine candidates

Anna Henningham, Emiliano Chiarot, Christine M. Gillen et al. · Journal of Molecular Medicine · 2012 · 61 citations · Full text

Vaccination, Vaccine Development, Medicine +9

A Synthetic M Protein Peptide Synergizes with a CXC Chemokine Protease To Induce Vaccine-Mediated Protection against Virulent Streptococcal Pyoderma and Bacteremia

Manisha Pandey, Emma L. Langshaw, Jon Hartas et al. · The Journal of Immunology · 2015 · 57 citations

Combination Vaccine, Immunology, Vaccine Target +18